You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
PSMA-Specific CAR-Engineered T Cells for Prostate Cancer: CD28 Outperforms Combined CD28-4-1BB “Super-Stimulation”
|
|---|---|
| Published in |
Frontiers in oncology, September 2021
|
| DOI | 10.3389/fonc.2021.708073 |
| Pubmed ID | |
| Authors |
Gaia Zuccolotto, Alessandro Penna, Giulio Fracasso, Debora Carpanese, Isabella Monia Montagner, Silvia Dalla Santa, Antonio Rosato |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 2 | 29% |
| United States | 1 | 14% |
| Switzerland | 1 | 14% |
| Unknown | 3 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 7 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 26 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 23% |
| Other | 3 | 12% |
| Student > Ph. D. Student | 2 | 8% |
| Student > Master | 2 | 8% |
| Student > Bachelor | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 11 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Immunology and Microbiology | 6 | 23% |
| Biochemistry, Genetics and Molecular Biology | 3 | 12% |
| Medicine and Dentistry | 2 | 8% |
| Agricultural and Biological Sciences | 2 | 8% |
| Unspecified | 1 | 4% |
| Other | 0 | 0% |
| Unknown | 12 | 46% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 October 2021.
All research outputs
#8,172,001
of 25,392,582 outputs
Outputs from Frontiers in oncology
#2,996
of 22,436 outputs
Outputs of similar age
#154,251
of 435,697 outputs
Outputs of similar age from Frontiers in oncology
#155
of 1,446 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 22,436 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,697 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 64% of its contemporaries.
We're also able to compare this research output to 1,446 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.